NEW YORK (GenomeWeb News) – Biocrates Life Sciences said today that it has forged a worldwide co-marketing agreement with Applied Biosystems focused on the metabolomics market.
Innsbruck, Austria-based Biocrates will promote ABI’s mass spectrometers for targeted metabolomics and for use in combination with its AbsoluteIDQ kits. In return, ABI will promote Biocrates’ AbsolteIDQ kits for targeted metabolomics in combination with its triple quadrupole and QTRAP series instruments.
Biocrates launched the AbsoluteIDQ kit at the recent Aanalytica meeting in Munich, Germany. The kits are initially available only in Europe, but the firm plans to expand sales to the US and eventually the rest of the world, it said.
“Metabolomics is a growing field expected to expand the market for mass spectrometers worldwide,” Tamara Bond, senior director of the pharmaceutical business at ABI, said in a statement.
The firms expect to jointly market the combined technologies at upcoming conferences including the American Society of Mass Spectrometry in Denver, Colo., next week.